Sinopharm
1099.HK
HK$17.96
Share price
0.00%
Change (1 day)
-9.06%
Change (1 year)
Categories
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.
EPS for Sinopharm (1099.HK)
EPS in 2022: HK$3.07
According to Sinopharm's latest financial reports the company's current EPS (TTM) is HK$3.07. In 2022 the company made an earnings per share (EPS) of HK$3.07 an increase over its 2021 EPS that were of HK$3.03.
EPS history for Sinopharm from 2006 to 2022
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2022 | HK$3.07 | 1.3% |
| 2021 | HK$3.03 | 10.33% |
| 2020 | HK$2.75 | 17.26% |
| 2019 | HK$2.34 | 5.44% |
| 2018 | HK$2.22 | -0.87% |
| 2017 | HK$2.24 | 19.44% |
| 2016 | HK$1.88 | 15.3% |
| 2015 | HK$1.63 | 17.06% |
| 2014 | HK$1.39 | 21.9% |
| 2013 | HK$1.14 | 11.82% |
| 2012 | HK$1.02 | 25.24% |
| 2011 | HK$0.81 | 31.02% |
| 2010 | HK$0.62 | 3.3% |
| 2009 | HK$0.60 | 46.85% |
| 2008 | HK$0.41 | 67.57% |
| 2007 | HK$0.24 | 310.24% |
| 2006 | HK$0.05963 |